# Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-tolvaptan-in-patients-with-malignant-ascites-a-phase-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Toshihiro Kudo,Yoshiyuki Murai,Yoshitsugu Kojima,Kenji Uehara,Taroh Satoh |
| Citations | 5 |
| DOI | 10.1093/jjco/hyaa196 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/jjco/article-pdf/51/3/354/36446195/hyaa196.pdf |
| OpenAlex ID | https://openalex.org/W3102316734 |
| PMID | 33173939 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yoshitsugu Kojima](https://scholariq.org/researchers/yoshitsugu-kojima/)

## Paper primary topic

- [Nausea and vomiting management](https://scholariq.org/topics/nausea-and-vomiting-management/)

## Paper topics

- [Nausea and vomiting management](https://scholariq.org/topics/nausea-and-vomiting-management/)
- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Chemotherapy-induced organ toxicity mitigation](https://scholariq.org/topics/chemotherapy-induced-organ-toxicity-mitigation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.